IDNA at the 31st National Greek Psychiatric Summit

We are proud to announce the participation of our client, iDNA Genomics Public Ltd at the 31st National Greek Psychiatric Summit which took place at the Rodos Palace Hotel in Rodos, Greece between the 25th and 28th of May 2023.

The Summit focused on the increased rates of depression in Greece and worldwide, where the IDNA team were able to update the participants on the recent approval of its PGx-CNS product, the only certified CE Mark in-vitro diagnostic test, to be covered by the Greek National Health Service. 

The full press release is available here or visit IDNA’s investor relations portal.